XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -9.87%461.29M | -27.62%1.04B | -27.98%511.83M | 40.62%1.43B | 70.17%710.7M | 77.80%1.02B | 44.27%417.64M | -24.29%572.47M | -19.23%289.5M | -4.26%756.09M |
Operating income | -9.87%461.29M | -27.62%1.04B | -27.98%511.83M | 40.62%1.43B | 70.17%710.7M | 77.80%1.02B | 44.27%417.64M | -24.29%572.47M | -19.23%289.5M | -4.26%756.09M |
Cost of sales | -4.25%-110.81M | 15.65%-216.39M | 19.02%-106.29M | 2.39%-256.53M | -30.24%-131.26M | -28.66%-262.8M | -101.74%-100.78M | -53.57%-204.26M | 5.35%-49.96M | 3.63%-133.01M |
Operating expenses | -4.25%-110.81M | 15.65%-216.39M | 19.02%-106.29M | 2.39%-256.53M | -30.24%-131.26M | -28.66%-262.8M | -101.74%-100.78M | -53.57%-204.26M | 5.35%-49.96M | 3.63%-133.01M |
Gross profit | -13.58%350.48M | -30.23%819.6M | -30.01%405.54M | 55.59%1.17B | 82.87%579.44M | 105.06%755.04M | 32.28%316.86M | -40.91%368.21M | -21.63%239.54M | -4.39%623.09M |
Selling expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -11.45%-8.71M | -5.38%-16.64M |
Administrative expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 49.85%-26.91M | -31.20%-158.16M |
Employee expense | 2.27%-46.18M | -2.00%-94.94M | 2.80%-47.25M | 8.62%-93.09M | 5.28%-48.61M | 0.04%-101.87M | -2.57%-51.32M | 28.92%-101.91M | 13.29%-50.04M | 7.95%-143.37M |
Depreciation and amortization | 5.46%-173.04M | 4.93%-367.76M | 2.67%-183.04M | -46.57%-386.83M | -48.49%-188.06M | -5.50%-263.92M | 30.30%-126.64M | 28.27%-250.16M | -6.47%-181.71M | -5.90%-348.75M |
Impairment and provision | ---- | 99.24%-348K | ---- | -127.58%-45.77M | ---- | 132.51%165.98M | 96.91%-15.67M | 27.38%-510.49M | -1,774.84%-507.63M | -358.12%-702.98M |
-Other impairment is provision | ---- | 99.24%-348K | ---- | -127.58%-45.77M | ---- | 132.51%165.98M | 96.91%-15.67M | 27.38%-510.49M | -1,774.84%-507.63M | -358.12%-702.98M |
Special items of operating profit | -52.64%7.3M | -99.93%1.83M | -99.41%15.42M | 28,393.50%2.59B | 94,647.07%2.61B | 198.43%9.11M | -27.41%2.75M | 103.78%3.05M | 109.83%3.79M | -92.86%-80.72M |
Operating profit | -33.56%113.61M | -90.02%309.79M | -94.05%171M | 467.60%3.1B | 2,257.58%2.88B | 209.75%546.69M | 122.80%122M | 40.37%-498.11M | -898.27%-535.12M | -354.28%-835.39M |
Financing income | -3.41%85K | 51.82%167K | 144.44%88K | -99.38%110K | -99.77%36K | -49.71%17.77M | -40.63%15.68M | -16.88%35.34M | 269.45%26.41M | 88.11%42.52M |
Financing cost | -0.78%-193.88M | 35.69%-383.67M | 45.01%-192.39M | 25.69%-596.6M | 12.03%-349.87M | 5.09%-802.89M | -22.80%-397.71M | -39.64%-845.95M | -9.91%-323.87M | 1.39%-605.8M |
Earning before tax | -276.58%-80.19M | -102.94%-73.71M | -100.84%-21.29M | 1,151.28%2.51B | 1,071.63%2.53B | 81.78%-238.43M | 68.77%-260.03M | 6.43%-1.31B | -144.08%-832.59M | -78.18%-1.4B |
Tax | 23.75%-29.9M | 34.37%-83.82M | 43.66%-39.21M | -27.79%-127.71M | -55.92%-69.61M | -134.64%-99.94M | -2,267.02%-44.64M | 31.80%-42.59M | 91.59%-1.89M | -31.72%-62.45M |
After-tax profit from continuing operations | -81.94%-110.09M | -106.62%-157.53M | -102.46%-60.51M | 803.03%2.38B | 906.41%2.46B | 74.96%-338.36M | 63.49%-304.67M | 7.52%-1.35B | -129.55%-834.47M | -75.54%-1.46B |
After-tax profit from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 191.39%332.18M |
Earning after tax | -81.94%-110.09M | -106.62%-157.53M | -102.46%-60.51M | 803.03%2.38B | 906.41%2.46B | 74.96%-338.36M | 63.49%-304.67M | -19.70%-1.35B | -39.72%-834.47M | 5.59%-1.13B |
Minority profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -9,214.29%-3.91M |
Shareholders should account for profits from continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -75.08%-1.46B |
Shareholders should account for profits from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 191.39%332.18M |
Profit attributable to shareholders | -81.94%-110.09M | -106.62%-157.53M | -102.46%-60.51M | 803.03%2.38B | 906.41%2.46B | 74.96%-338.36M | 63.49%-304.67M | -20.11%-1.35B | -40.28%-834.47M | 5.92%-1.13B |
Basic earnings per share | -50.00%-0.03 | -106.94%-0.05 | -102.67%-0.02 | 820.00%0.72 | 933.33%0.75 | 75.61%-0.1 | 65.38%-0.09 | -17.14%-0.41 | -31.98%-0.26 | 14.63%-0.35 |
Diluted earnings per share | -50.00%-0.03 | -107.14%-0.05 | -102.70%-0.02 | 800.00%0.7 | 922.22%0.74 | 75.61%-0.1 | 65.38%-0.09 | -17.14%-0.41 | -31.98%-0.26 | 14.63%-0.35 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Auditor | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.